• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米囊泡载体增强氟康唑的经皮递药:一种治疗真菌感染的新方法。

Novasomes as Nano-Vesicular Carriers to Enhance Topical Delivery of Fluconazole: A New Approach to Treat Fungal Infections.

机构信息

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan.

Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan.

出版信息

Molecules. 2022 May 4;27(9):2936. doi: 10.3390/molecules27092936.

DOI:10.3390/molecules27092936
PMID:35566287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103678/
Abstract

The occurrence of fungal infections has increased over the past two decades. It is observed that superficial fungal infections are treated by conventional dosage forms, which are incapable of treating deep infections due to the barrier activity possessed by the stratum corneum of the skin. This is why the need for a topical preparation with advanced penetration techniques has arisen. This research aimed to encapsulate fluconazole (FLZ) in a novasome in order to improve the topical delivery. The novasomes were prepared using the ethanol injection technique and characterized for percent entrapment efficiency (EE), particle size (PS), zeta potential (ZP), drug release, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), scanning electron microscopy (SEM) and antifungal activity. The FN7 formulation with 94.45% EE, 110 nm PS and -24 ZP proved to be the best formulation. The FN7 formulation showed a 96% release of FLZ in 8 h. FTIR showed the compatibility of FLZ with excipients and DSC studies confirmed the thermal stability of FLZ in the developed formulation. The FN7 formulation showed superior inhibition of the growth of compared to the FLZ suspension using a resazurin reduction assay, suggesting high efficacy in inhibiting fungal growth.

摘要

在过去的二十年中,真菌感染的发生率有所增加。人们观察到,浅表真菌感染采用常规剂型治疗,由于皮肤角质层具有屏障活性,这些常规剂型无法治疗深部感染。这就是为什么需要一种具有先进渗透技术的局部制剂的原因。本研究旨在将氟康唑(FLZ)包封在新星体中,以改善局部传递。新星体是通过乙醇注入技术制备的,并对包封效率(EE)、粒径(PS)、Zeta 电位(ZP)、药物释放、傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)、热重分析(TGA)、扫描电子显微镜(SEM)和抗真菌活性进行了表征。具有 94.45% EE、110nm PS 和-24 ZP 的 FN7 制剂被证明是最佳制剂。FN7 制剂在 8 小时内释放了 96%的 FLZ。FTIR 表明 FLZ 与赋形剂具有相容性,DSC 研究证实了 FLZ 在开发制剂中的热稳定性。与 FLZ 混悬剂相比,FN7 制剂在使用 Resazurin 还原测定法时对 的生长表现出更好的抑制作用,表明其在抑制真菌生长方面具有很高的功效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/f5938b4bf52e/molecules-27-02936-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/05283f56a78c/molecules-27-02936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/45f98e04c4ee/molecules-27-02936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/5675296e550c/molecules-27-02936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/2d14d6a95df7/molecules-27-02936-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/fb872678a949/molecules-27-02936-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/f5938b4bf52e/molecules-27-02936-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/05283f56a78c/molecules-27-02936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/45f98e04c4ee/molecules-27-02936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/5675296e550c/molecules-27-02936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/2d14d6a95df7/molecules-27-02936-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/fb872678a949/molecules-27-02936-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28cc/9103678/f5938b4bf52e/molecules-27-02936-g006.jpg

相似文献

1
Novasomes as Nano-Vesicular Carriers to Enhance Topical Delivery of Fluconazole: A New Approach to Treat Fungal Infections.纳米囊泡载体增强氟康唑的经皮递药:一种治疗真菌感染的新方法。
Molecules. 2022 May 4;27(9):2936. doi: 10.3390/molecules27092936.
2
Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.利用诺瓦索体作为囊泡载体提高特康唑的经皮递药效果:体外特性研究、体内评价和探索性临床实验。
Int J Nanomedicine. 2021 Jan 8;16:119-132. doi: 10.2147/IJN.S287383. eCollection 2021.
3
Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system.克服氟康唑耐药性念珠菌分离株的时间:固体脂质纳米粒作为一种新型抗真菌药物传递系统。
Colloids Surf B Biointerfaces. 2016 Jun 1;142:400-407. doi: 10.1016/j.colsurfb.2016.03.013. Epub 2016 Mar 5.
4
Biodegradable Polymers-based Nanoparticles to Enhance the Antifungal Efficacy of Fluconazole against .基于可生物降解聚合物的纳米粒子增强氟康唑抗. 的抗真菌疗效
Curr Pharm Biotechnol. 2022;23(5):749-757. doi: 10.2174/1389201022666210708105142.
5
Revolutionizing treatment for topical fungal infections: evaluating penetration-enhancer-containing vesicles as a fluconazole delivery system: and dermal testing.颠覆局部真菌感染治疗方式:评估含促透剂囊泡作为氟康唑递药系统:体外和皮肤试验。
Pharm Dev Technol. 2024 Oct;29(8):814-823. doi: 10.1080/10837450.2024.2394573. Epub 2024 Aug 22.
6
Development of novel biopolymer-based nanoparticles loaded cream for potential treatment of topical fungal infections.新型生物聚合物载药乳膏的研制及其用于局部真菌感染治疗的潜力。
Drug Dev Ind Pharm. 2021 Jul;47(7):1090-1099. doi: 10.1080/03639045.2021.1957914. Epub 2021 Aug 6.
7
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.氟康唑负载固体脂质纳米粒局部凝胶治疗花斑癣:制剂与临床研究。
Drug Deliv. 2018 Nov;25(1):78-90. doi: 10.1080/10717544.2017.1413444.
8
Enhanced systematic delivery of fluconazole-loaded biotin-glutathione functionalized chitosan-g-proline carrier into the infected retinitis treatment.增强型氟康唑负载生物素-谷胱甘肽功能化壳聚糖-g-脯氨酸载体递送至感染性视网膜炎治疗中。
BMC Ophthalmol. 2024 Jan 30;24(1):48. doi: 10.1186/s12886-024-03305-z.
9
Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.载透明质酸凝胶脂质体作为一种新型眼部纳米给药系统的氟康唑具有良好的长效作用。
Int J Pharm. 2017 Dec 20;534(1-2):14-24. doi: 10.1016/j.ijpharm.2017.10.007. Epub 2017 Oct 4.
10
Assembly and antifungal effect of a new fluconazole-carrier nanosystem.新型氟康唑载体纳米系统的组装及抗真菌作用。
Future Microbiol. 2020 Mar;15:273-285. doi: 10.2217/fmb-2019-0182.

引用本文的文献

1
Nasal In-Situ Gels of Brij-Enriched Novasomes as Optimistic Nanovesicular Carriers for Enhancing Anti-Depressant Action of Agomelatine.富含月桂醇聚醚的新型脂质体鼻腔原位凝胶作为增强阿戈美拉汀抗抑郁作用的理想纳米囊泡载体
AAPS PharmSciTech. 2025 Apr 17;26(5):110. doi: 10.1208/s12249-025-03097-5.
2
The progress and future of the treatment of Candida albicans infections based on nanotechnology.基于纳米技术的白念珠菌感染治疗的进展与未来。
J Nanobiotechnology. 2024 Sep 16;22(1):568. doi: 10.1186/s12951-024-02841-6.
3
Thyme Oil-Containing Fluconazole-Loaded Transferosomal Bigel for Transdermal Delivery.

本文引用的文献

1
Proniosome: A Promising Approach for Vesicular Drug Delivery.前质体:一种有前景的囊泡药物递送方法。
Turk J Pharm Sci. 2022 Aug 31;19(4):462-475. doi: 10.4274/tjps.galenos.2021.53533.
2
Formulation Development, Characterization and Antifungal Evaluation of Chitosan NPs for Topical Delivery of Voriconazole In Vitro and Ex Vivo.伏立康唑壳聚糖纳米粒的制剂开发、表征及体外和离体局部给药的抗真菌评价
Polymers (Basel). 2021 Dec 30;14(1):135. doi: 10.3390/polym14010135.
3
A Review on Ocular Novel Drug Delivery Systems of Antifungal Drugs: Functional Evaluation and Comparison of Conventional and Novel Dosage Forms.
含百里香精油的氟康唑载药传递体巴布剂经皮给药系统。
AAPS PharmSciTech. 2023 Nov 21;24(8):240. doi: 10.1208/s12249-023-02698-2.
4
Development and Pharmacokinetic Evaluation of Novasomes for the Trans-nasal Delivery of Fluvoxamine Using Arachidonic Acid-Carboxymethyl Chitosan Conjugate.使用花生四烯酸-羧甲基壳聚糖缀合物的新型脂质体用于氟伏沙明经鼻递送的研发及药代动力学评价
Pharmaceutics. 2023 Aug 31;15(9):2259. doi: 10.3390/pharmaceutics15092259.
5
Nanotechnology-based Drug Delivery of Topical Antifungal Agents.基于纳米技术的局部抗真菌药物传递。
Pharm Nanotechnol. 2024;12(3):185-196. doi: 10.2174/2211738511666230818125031.
6
Recent Advances of Chitosan Formulations in Biomedical Applications.壳聚糖制剂在生物医学应用中的最新进展。
Int J Mol Sci. 2022 Sep 19;23(18):10975. doi: 10.3390/ijms231810975.
7
Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art.海藻酸盐作为一种有前途的药物输送和伤口愈合生物聚合物:最新技术综述。
Int J Mol Sci. 2022 Aug 12;23(16):9035. doi: 10.3390/ijms23169035.
抗真菌药物眼部新型给药系统综述:传统剂型与新型剂型的功能评估及比较
Adv Pharm Bull. 2021 Jan;11(1):28-38. doi: 10.34172/apb.2021.003. Epub 2020 Nov 7.
4
Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.利用诺瓦索体作为囊泡载体提高特康唑的经皮递药效果:体外特性研究、体内评价和探索性临床实验。
Int J Nanomedicine. 2021 Jan 8;16:119-132. doi: 10.2147/IJN.S287383. eCollection 2021.
5
Synergistic Antifungal Activity of Chitosan with Fluconazole against , , and Fluconazole-Resistant Strains.壳聚糖与氟康唑联合抗 、 、 和氟康唑耐药菌株的协同抗真菌活性。
Molecules. 2020 Nov 3;25(21):5114. doi: 10.3390/molecules25215114.
6
Modulation of Entrapment Efficiency and In Vitro Release Properties of BSA-Loaded Chitosan Microparticles Cross-Linked with Citric Acid as a Potential Protein-Drug Delivery System.作为一种潜在的蛋白质药物递送系统,对用柠檬酸交联的载牛血清白蛋白壳聚糖微粒的包封率和体外释放特性的调控
Materials (Basel). 2020 Apr 24;13(8):1989. doi: 10.3390/ma13081989.
7
Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies.负载螺内酯的卵磷脂复合物作为女性痤疮潜在的局部给药系统:体外评估和离体皮肤渗透性研究
Pharmaceutics. 2019 Dec 25;12(1):25. doi: 10.3390/pharmaceutics12010025.
8
Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions.氟康唑亚稳晶型II在无定形固体分散体中的稳定性及生长
Pharmaceutics. 2019 Dec 20;12(1):12. doi: 10.3390/pharmaceutics12010012.
9
Zeta Potential of Beta Zeolites: Influence of Structure, Acidity, pH, Temperature and Concentration.β沸石的 ζ 电位:结构、酸度、pH 值、温度和浓度的影响。
Molecules. 2018 Apr 18;23(4):946. doi: 10.3390/molecules23040946.
10
Methods for evaluating antimicrobial activity: A review.抗菌活性评估方法:综述
J Pharm Anal. 2016 Apr;6(2):71-79. doi: 10.1016/j.jpha.2015.11.005. Epub 2015 Dec 2.